share_log

Needham Maintains Buy on Revolution Medicines, Raises Price Target to $46

Needham Maintains Buy on Revolution Medicines, Raises Price Target to $46

Needham维持对Revolution Medicines的买入,将目标股价上调至46美元
Moomoo 24/7 ·  04/12 06:15

Needham analyst Ami Fadia maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $36 to $46.

尼德姆分析师阿米·法迪亚维持Revolution Medicines(纳斯达克股票代码:RVMD)的买入并将目标股价从36美元上调至46美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发